Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 7/2024

Inhalt (20 Artikel)

Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data

  • Open Access
  • Research

Justin C. Moser, Shailender Bhatia, Asim Amin, Anna C. Pavlick, Keith A. Betts, Ella Xiaoyan Du, Tayla Poretta, Karishma Shelley, Swetha Srinivasan, Leon Alan Sakkal, Jennell Palaia, Maurice Lobo, Melanie Pe Benito, Joshua A. Linton, Yan Chen, Churong Xu, Lei Yin, Manasvi Sundar, Jeffrey Weber

Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer

  • Open Access
  • Research

Yansong Liu, Mingcui Li, Zhengbo Fang, Shan Gao, Weilun Cheng, Yunqiang Duan, Xuelian Wang, Jianyuan Feng, Tianshui Yu, Jiarui Zhang, Ting Wang, Anbang Hu, Hanyu Zhang, Zhiyuan Rong, Suborna S. Shakila, Yuhang Shang, Fanjing Kong, Jiangwei Liu, Yanling Li, Fei Ma

Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy

  • Open Access
  • Brief Report

Barbara Bailly-Caillé, Romain Levard, Diane Kottler, Anne Dompmartin, Jean-Matthieu L’Orphelin

Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer

  • Open Access
  • Research

Panpan Zhang, Zhendong Chen, Si Shi, Zhiping Li, Feng Ye, Lijie Song, Yanqiao Zhang, Fei Yin, Xing Zhang, Jianming Xu, Ying Cheng, Weiguo Su, Michael Shi, Songhua Fan, Panfeng Tan, Chen Zhong, Ming Lu, Lin Shen

Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study

  • Open Access
  • Research

Song Guan, Jifeng Sun, Yuan Wang, Sibei Han, Chen Chen, Dongsheng Yue, Yubei Huang, Kai Ren, Jun Wang, Jun Wang, Lujun Zhao

Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma

  • Open Access
  • Research

Xin Wu, Tao Mi, Liming Jin, Chunnian Ren, Jinkui Wang, Zhaoxia Zhang, Jiayan Liu, Zhaoyin Wang, Peng Guo, Dawei He

Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score

  • Open Access
  • Brief Report

Chaoting Zhang, Shance Li, Luyan Shen, Xia Teng, Yefei Xiao, Wenjun Yang, Zheming Lu

Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study

  • Open Access
  • Research

Shengxiang Ren, Anwen Xiong, Jia Yu, Xicheng Wang, Baohui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Sheng Hu, Tianshu Liu, Yalun Li, Ying Cheng, Jifeng Feng, Shanyong Yi, Shanzhi Gu, Shegan Gao, Yongzhong Luo, Ying Liu, Caigang Liu, Huijie Duan, Shuni Wang, Xinfeng Yang, Jia Fan, Caicun Zhou

The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis

  • Open Access
  • Research

Ya-Nan Jin, Meng-Yun Qiang, Ying Wang, Yu-Jing Lin, Ren-Wei Jiang, Wan-Wei Cao, Wang-Jian Zhang, Si-Yang Wang, Hong-Yu Zhang, Ji-Jin Yao

Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study

  • Open Access
  • Research

Tatsuki Ikoma, Toshihiko Matsumoto, Shogen Boku, Yusuke Motoki, Hidefumi Kinoshita, Hisashi Kosaka, Masaki Kaibori, Kentaro Inoue, Mitsugu Sekimoto, Takuo Fujisawa, Hiroshi Iwai, Makoto Naganuma, Hideaki Tanizaki, Yoji Hisamatsu, Hidetaka Okada, Takayasu Kurata

Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment

  • Open Access
  • Research

Peng Zhang, Yi Wan, Jinrong Ma, Jin Gong, Ziwei Zhong, Yuxin Cui, Hongli Zhang, Yanyan Da, Junpeng Ma, Chenxi Li, Lijuan Liu, Tian Gong, Youwen Tan, Chengsheng Zhang

Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer

  • Open Access
  • Research

Fenbao Lian, Haitao Yang, Rujun Hong, Hang Xu, Tingting Yu, Gang Sun, Guanying Zheng, Baosong Xie

GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration

  • Open Access
  • Research

Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao

The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis

  • Open Access
  • Research

Ji-Bin Li, Ming-Yu Lai, Zhuo-Chen Lin, Wen-Long Guan, Yu-Ting Sun, Jing Yang, Wen-Xuan Wang, Zhi-Rong Yang, Miao-Zhen Qiu

Effect of radiochemotherapy on peripheral immune response in glioblastoma

  • Open Access
  • Research

Léa Hampe, Susy Daumoine, Emeric Limagne, Nicolas Roussot, François Borsotti, Julie Vincent, Sylvia Ilie, Caroline Truntzer, François Ghiringhelli, Marion Thibaudin

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

  • Open Access
  • Research

Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, Yoko Adachi, Naoyuki Anzai, Masaaki Hotta, Kentaro Fukushima, Hideo Yagi, Satoshi Yoshihara, Yasuhiro Tanaka, Teruhito Takakuwa, Hirokazu Tanaka, Hirohiko Shibayama, Nobuhiko Uoshima, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino

Neu im Fachgebiet Onkologie

Dänische Zwillingsstudie deutet auf erhöhtes Krebsrisiko bei Tätowierten hin

Haben Tattoo-Träger und -Trägerinnen ein erhöhtes Risiko, an Hautkrebs oder einem Lymphom zu erkranken? Die Ergebnisse einer Zwillingsstudie aus Dänemark scheinen dafür zu sprechen. Die Forschungsgruppe rät vorerst zur Zurückhaltung beim Tätowieren.

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Muss man wirklich auch die letzte Krebszelle eliminieren?

Genauere Prognoseabschätzung, bessere Therapiesteuerung und eine schnellere Entwicklung innovativer Behandlungsansätze – der Messung der minimalen Resterkrankung (MRD) wird ein enormes Potenzial attestiert. Eine Übersichtsarbeit unterstreicht jetzt aber: Es gibt noch blinde Flecken.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.